Literature DB >> 4826937

In vivo analysis of adrenergic receptor activity of dobutamine.

N W Robie, D O Nutter, C Moody, J L McNay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4826937     DOI： 10.1161/01.res.34.5.663

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  22 in total

1.  Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogs.

Authors:  A Dorszewski; B Müller-Beckmann; L Kling; G Sponer
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

2.  Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62.

Authors:  G Johnsson; L Jordö; P Lundborg; O Rönn; I Welin-Fogelberg; J Wikstrand
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

3.  The effect of (+/-)-dobutamine on adrenergic nerve endings.

Authors:  P Fischer; A Burger; K H Graefe; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

4.  Assessing cardiac pumping capability by exercise testing and inotropic stimulation.

Authors:  L B Tan; R J Bain; W A Littler
Journal:  Br Heart J       Date:  1989-07

5.  Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists.

Authors:  E Carlsson; C G Dahlöf; A Hedberg; H Persson; B Tångstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

Review 6.  Inotropic drugs in acute circulatory failure.

Authors:  P Herbert; J Tinker
Journal:  Intensive Care Med       Date:  1980       Impact factor: 17.440

7.  Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.

Authors:  R A Brown; J Dixon; J B Farmer; J C Hall; R G Humphries; F Ince; S E O'Connor; W T Simpson; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

8.  Comparison of dobutamine and dopamine in treatment of severe heart failure.

Authors:  J D Stoner; J L Bolen; D C Harrison
Journal:  Br Heart J       Date:  1977-05

9.  The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.

Authors:  A Nuttall; H M Snow
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

10.  Comparison of the cardiodynamic and metabolic effects of dobutamine with those of norepinephrine and dopamine in the dog isolated heart.

Authors:  J A Simaan; G Fawaz; K Jabbour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.